CAR T cell cancer immunotherapy. Illustration of CAR (chimeric antigen receptor) T cell immunotherapy, a process that is being developed to treat cancer. The first stage involves taking T cells (a type of white blood cell) from the patient (cell shown at centre). These cells are then treated with a virus (spiky objects) that transfers DNA (deoxyribonucleic acid) to the T cells (a form of genetic engineering) that results in them producing chimeric antigen receptor (CAR) proteins. These proteins will be specific to the patient's cancer. These modified T cells are then grown in the laboratory and used to treat the patient. The technique is known as adoptive cell transfer (ACT). | |
Lizenzart: | Lizenzpflichtig |
Credit: | Science Photo Library / KEITH CHAMBERS |
Bildgröße: | 6096 px × 3840 px |
Modell-Rechte: | nicht erforderlich |
Eigentums-Rechte: | nicht erforderlich |
Restrictions: | - |